CD8A and neoplasm: Although this type of chemokine induction is totally different from that induced by DPP4 inhibitors, 2-DG-PLGA-NPs also enhance CD8+ T cell infiltration into liver tumors, and not only amplified the anti-tumor effects induced by the anti-PD1 antibody but also suppressed anti-PD1-resistant tumors [54].